These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15799377)

  • 21. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibody-induced arthritis].
    Yamashita A; Yonemitsu Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():46-50. PubMed ID: 15799316
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunologic tests: Anti citrullinated protein (filaggrin/CCP) antibodies].
    Mimori T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():472-5. PubMed ID: 16111305
    [No Abstract]   [Full Text] [Related]  

  • 25. [RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies)].
    Tanaka M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():449-52. PubMed ID: 16111298
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K
    Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
    Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
    Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.
    Li J; Guo Y; Holmdahl R; Ny T
    Arthritis Rheum; 2005 Aug; 52(8):2541-8. PubMed ID: 16052596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [immunological and serological tests for diagnosis of rheumatoid arthritis: antinuclear antibodies].
    Hirakata M; Kaneko Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():333-40. PubMed ID: 15799373
    [No Abstract]   [Full Text] [Related]  

  • 31. Is assaying autoantibodies useful for diagnosing early rheumatoid arthritis?
    van Venrooij WJ; van de Putte LB
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):4-5. PubMed ID: 16932618
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunological and serological tests for diagnosis of rheumatoid arthritis: anti-agalactosyl IgG antibody].
    Atsumi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():328-31. PubMed ID: 15799372
    [No Abstract]   [Full Text] [Related]  

  • 33. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
    Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
    Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
    Nandakumar KS; Bajtner E; Hill L; Böhm B; Rowley MJ; Burkhardt H; Holmdahl R
    Arthritis Rheum; 2008 Jan; 58(1):184-96. PubMed ID: 18163493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
    Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
    Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen antibody-induced arthritis.
    Khachigian LM
    Nat Protoc; 2006; 1(5):2512-6. PubMed ID: 17406499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antifilaggrin antibody as a serological marker for the diagnosis of rheumatoid arthritis].
    Nakazono K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():351-4. PubMed ID: 15799376
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.